NCSED Chooses Instem’s Integrated Software Suite for Preclinical Studies in China  
12/8/2011 7:21:30 AM

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of early development software applications, announced today that China’s National Center for Safety Evaluation of Drugs (NCSED) has selected Instem’s Provantis® software solution suite to automate their preclinical study processes.